Article Type
News
Changed
Tue, 10/24/2023 - 00:34
Author(s)
By Lisa O'Mary
The Food and Drug Administration is considering banning chemicals used in hair straightening products that have been linked to cancer.
Theproposalspecifies that formaldehyde would be banned, as well as other chemicals that release formaldehyde, such as methylene glycol.Using hair smoothing products containing formaldehyde and formaldehyde-releasing chemicals “is linked to short-term adverse health effects, such as sensitization reactions and breathing problems, and long-term adverse health effects, including an increased risk of certain cancers,” theproposalstates.
Onestudypublished last year showed that repeated use of hair straightening products, also called relaxers, could more than double the risk of uterine cancer. Although that study didn’t find that the uterine cancer risk varied based on a person’s race, theresearchers notedthat women who are Black are among the most likely to use the products and tend to start using them at younger ages, compared with people of other races and ethnicities.
Hair straightening products have also been linked to elevated risks of hormone-sensitive cancers, such as breast cancer and ovarian cancer.
Rep. Ayanna Pressley (D-Mass.) and Rep. Shontel Brown (D-Ohio) applauded the proposed rule in a statementissued jointly on Oct. 6. “The FDA’s proposal to ban these harmful chemicals in hair straighteners and relaxers is a win for public health – especially the health of Black women who are disproportionately put at risk by these products as a result of systemic racism and anti–Black hair sentiment,” Rep. Pressley said The two congresswomen wrote a letter to the FDA earlier this year requesting the topic be investigated.
“Regardless of how we wear our hair, we should be allowed to show up in the world without putting our health at risk. I applaud the FDA for being responsive to our calls and advancing a rule that will help prevent manufacturers from making a profit at the expense of our health,” Rep. Pressley said in the statement. “The administration should finalize this rule without delay.”
A version of this article appeared on WebMD.com
Publications
MDedge Dermatology
Dermatology News
Clinical Endocrinology News
Family Practice News
Internal Medicine News
Hematology News
Oncology Practice
Ob.Gyn. News
Pediatric News
MDedge Endocrinology
MDedge Family Medicine
MDedge Internal Medicine
MDedge Hematology and Oncology
MDedge ObGyn
MDedge Pediatrics
Clinician Reviews
Federal Practitioner
AVAHO
Topics
Aesthetic Dermatology
Mixed Topics
Dermatology
Oncology
Diversity in Medicine
Breast Cancer
Sections
Latest News
FDA/CDC
News
Author(s)
By Lisa O'Mary
Author(s)
By Lisa O'Mary
The Food and Drug Administration is considering banning chemicals used in hair straightening products that have been linked to cancer.
Theproposalspecifies that formaldehyde would be banned, as well as other chemicals that release formaldehyde, such as methylene glycol.Using hair smoothing products containing formaldehyde and formaldehyde-releasing chemicals “is linked to short-term adverse health effects, such as sensitization reactions and breathing problems, and long-term adverse health effects, including an increased risk of certain cancers,” theproposalstates.
Onestudypublished last year showed that repeated use of hair straightening products, also called relaxers, could more than double the risk of uterine cancer. Although that study didn’t find that the uterine cancer risk varied based on a person’s race, theresearchers notedthat women who are Black are among the most likely to use the products and tend to start using them at younger ages, compared with people of other races and ethnicities.
Hair straightening products have also been linked to elevated risks of hormone-sensitive cancers, such as breast cancer and ovarian cancer.
Rep. Ayanna Pressley (D-Mass.) and Rep. Shontel Brown (D-Ohio) applauded the proposed rule in a statementissued jointly on Oct. 6. “The FDA’s proposal to ban these harmful chemicals in hair straighteners and relaxers is a win for public health – especially the health of Black women who are disproportionately put at risk by these products as a result of systemic racism and anti–Black hair sentiment,” Rep. Pressley said The two congresswomen wrote a letter to the FDA earlier this year requesting the topic be investigated.
“Regardless of how we wear our hair, we should be allowed to show up in the world without putting our health at risk. I applaud the FDA for being responsive to our calls and advancing a rule that will help prevent manufacturers from making a profit at the expense of our health,” Rep. Pressley said in the statement. “The administration should finalize this rule without delay.”
A version of this article appeared on WebMD.com
The Food and Drug Administration is considering banning chemicals used in hair straightening products that have been linked to cancer.
Theproposalspecifies that formaldehyde would be banned, as well as other chemicals that release formaldehyde, such as methylene glycol.Using hair smoothing products containing formaldehyde and formaldehyde-releasing chemicals “is linked to short-term adverse health effects, such as sensitization reactions and breathing problems, and long-term adverse health effects, including an increased risk of certain cancers,” theproposalstates.
Onestudypublished last year showed that repeated use of hair straightening products, also called relaxers, could more than double the risk of uterine cancer. Although that study didn’t find that the uterine cancer risk varied based on a person’s race, theresearchers notedthat women who are Black are among the most likely to use the products and tend to start using them at younger ages, compared with people of other races and ethnicities.
Hair straightening products have also been linked to elevated risks of hormone-sensitive cancers, such as breast cancer and ovarian cancer.
Rep. Ayanna Pressley (D-Mass.) and Rep. Shontel Brown (D-Ohio) applauded the proposed rule in a statementissued jointly on Oct. 6. “The FDA’s proposal to ban these harmful chemicals in hair straighteners and relaxers is a win for public health – especially the health of Black women who are disproportionately put at risk by these products as a result of systemic racism and anti–Black hair sentiment,” Rep. Pressley said The two congresswomen wrote a letter to the FDA earlier this year requesting the topic be investigated.
“Regardless of how we wear our hair, we should be allowed to show up in the world without putting our health at risk. I applaud the FDA for being responsive to our calls and advancing a rule that will help prevent manufacturers from making a profit at the expense of our health,” Rep. Pressley said in the statement. “The administration should finalize this rule without delay.”
A version of this article appeared on WebMD.com
Publications
MDedge Dermatology
Dermatology News
Clinical Endocrinology News
Family Practice News
Internal Medicine News
Hematology News
Oncology Practice
Ob.Gyn. News
Pediatric News
MDedge Endocrinology
MDedge Family Medicine
MDedge Internal Medicine
MDedge Hematology and Oncology
MDedge ObGyn
MDedge Pediatrics
Clinician Reviews
Federal Practitioner
AVAHO
Publications
MDedge Dermatology
Dermatology News
Clinical Endocrinology News
Family Practice News
Internal Medicine News
Hematology News
Oncology Practice
Ob.Gyn. News
Pediatric News
MDedge Endocrinology
MDedge Family Medicine
MDedge Internal Medicine
MDedge Hematology and Oncology
MDedge ObGyn
MDedge Pediatrics
Clinician Reviews
Federal Practitioner
AVAHO
Topics
Aesthetic Dermatology
Mixed Topics
Dermatology
Oncology
Diversity in Medicine
Breast Cancer
Article Type
News
Sections
Latest News
FDA/CDC
News
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article